Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion type Assertion NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_head.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion description "[The results demonstrate that patients with cGVHD had a higher incidence of HP 2-2 phenotype (43.8%), in comparison to the patients without cGVHD (0%) and normal donors (18.7%), suggesting the possibility that specific Hp polymorphism may play a role in the development of cGVHD after allo-HCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_provenance.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion evidence source_evidence_literature NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_provenance.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion SIO_000772 19379511 NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_provenance.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion wasDerivedFrom befree-20140225 NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_provenance.
- NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_assertion wasGeneratedBy ECO_0000203 NP612027.RA8u9pS1bgDOVRi9Oi0OC_KBgGt799sX1mVlKS2TCyWRg130_provenance.